🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate if the effectiveness of de...
Status
Completed
Location
Beijing Anding Hospital
Start Date
2020-06-18
Trial ID
NCT04364997
Treatments Being Tested
This is a double-blind study evaluating Desvenlafaxine Succinate Sustained-...
Status
Completed
Location
Children's Hospital of Alabama Laboratory
Start Date
2011-08
Trial ID
NCT01371734
Treatments Being Tested
This is a 6-month, open-label, flexible-dose study evaluating Desvenlafaxin...
Status
Completed
Location
The University Of Alabama At Birmingham, Office Of Psychiatric Research
Start Date
2012-02-02
Trial ID
NCT01371708
Treatments Being Tested
The main purpose of this study is to evaluate the effect of desvenlafaxine ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-06
Trial ID
NCT00952653
Treatments Being Tested
To evaluate the pharmacokinetics and safety of single dose and multiple dos...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-11
Trial ID
NCT01443208
Treatments Being Tested
To determine the bioequivalence of 2 tablets of 25 mg sustained release (SR...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-09
Trial ID
NCT01190514
This is a Double-blind Study Evaluating Desvenlafaxine Succinate (DVS SR) S...
Status
Completed
Location
Harmonex Neuroscience Research, Inc.
Start Date
2011-11-17
Trial ID
NCT01372150
Treatments Being Tested
The purpose of this study is to evaluate efficacy and safety of toludesvenl...
Status
Unknown
Location
Nanjing Brian Hospital
Start Date
2024-02-19
Trial ID
NCT06270433
Desvenlafaxine succinate (DVS SR) is a serotonin and norepinephrine reuptak...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-12
Trial ID
NCT00401245
Treatments Being Tested
The primary purpose of this study is to compare the long-term efficacy and ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-06
Trial ID
NCT00887224